LeonaBio, Inc. Depreciation
LeonaBio, Inc. (LONA) reported Depreciation of $200.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- LeonaBio, Inc. depreciation for the quarter ending 2026-06-30 was $200.00K, a 0.00% change year-over-year.
- LeonaBio, Inc. depreciation for the quarter ending 2026-03-31 was $231.00K, a 4.94% decline year-over-year.
- LeonaBio, Inc. depreciation for the quarter ending 2025-12-31 was $243.00K, a 0.00% change year-over-year.
- LeonaBio, Inc. depreciation for the quarter ending 2025-09-30 was $200.00K, a 0.00% change year-over-year.
- LeonaBio, Inc. depreciation for fiscal 2025 was $972.00K, a 0.21% increase from fiscal 2024.
- LeonaBio, Inc. depreciation for fiscal 2024 was $970.00K, a 0.10% increase from fiscal 2023.
- LeonaBio, Inc. depreciation for fiscal 2023 was $969.00K, a 14.67% increase from fiscal 2022.
- LeonaBio, Inc. depreciation for fiscal 2022 was $845.00K, a 76.41% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $200.00K 10-Q · filed 2026-08-14 | $458.00K 10-Q · filed 2026-08-14 | $674.00K derived: sum of 3 quarters · filed 2026-08-14 | $874.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $231.00K 10-Q · filed 2026-05-07 | $474.00K derived: sum of 2 quarters · filed 2026-05-07 | $674.00K derived: sum of 3 quarters · filed 2026-05-07 | $874.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $443.00K derived: sum of 2 quarters · filed 2026-03-31 | $643.00K derived: sum of 3 quarters · filed 2026-08-14 | $972.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-06 | $400.00K derived: sum of 2 quarters · filed 2026-08-14 | $729.00K 10-Q · filed 2025-11-06 | $886.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $200.00K 10-Q · filed 2026-08-14 | $486.00K 10-Q · filed 2026-08-14 | $686.00K derived: sum of 3 quarters · filed 2026-08-14 | $886.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $243.00K 10-Q · filed 2026-05-07 | $486.00K derived: sum of 2 quarters · filed 2026-05-07 | $686.00K derived: sum of 3 quarters · filed 2026-05-07 | $886.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $443.00K derived: sum of 2 quarters · filed 2026-03-31 | $643.00K derived: sum of 3 quarters · filed 2026-03-31 | $970.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-06 | $243.00K 10-Q · filed 2024-11-07 | $400.00K derived: sum of 2 quarters · filed 2025-11-06 | $727.00K 10-Q · filed 2025-11-06 | $887.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-07 | $242.00K 10-Q · filed 2024-08-01 | $484.00K 10-Q · filed 2025-08-07 | $687.00K derived: sum of 3 quarters · filed 2025-08-07 | $931.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $242.00K 10-Q · filed 2025-05-09 | $487.00K derived: sum of 2 quarters · filed 2025-05-09 | $731.00K derived: sum of 3 quarters · filed 2025-05-09 | $975.00K derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $489.00K derived: sum of 2 quarters · filed 2025-02-27 | $733.00K derived: sum of 3 quarters · filed 2025-02-27 | $969.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $244.00K 10-Q · filed 2024-11-07 | $488.00K derived: sum of 2 quarters · filed 2024-11-07 | $724.00K 10-Q · filed 2024-11-07 | $963.00K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $244.00K 10-Q · filed 2024-08-01 | $480.00K 10-Q · filed 2024-08-01 | $719.00K derived: sum of 3 quarters · filed 2024-08-01 | $950.00K derived: sum of 4 quarters · filed 2024-08-01 | |
| 2023-03-31 | $236.00K 10-Q · filed 2024-05-15 | $475.00K derived: sum of 2 quarters · filed 2024-05-15 | $706.00K derived: sum of 3 quarters · filed 2024-05-15 | $927.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $470.00K derived: sum of 2 quarters · filed 2024-02-22 | $691.00K derived: sum of 3 quarters · filed 2024-02-22 | $845.00K 10-K · filed 2024-02-22 | |
| 2022-09-30 | $231.00K 10-Q · filed 2023-11-09 | $452.00K derived: sum of 2 quarters · filed 2023-11-09 | $606.00K 10-Q · filed 2023-11-09 | $732.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $221.00K 10-Q · filed 2023-08-10 | $375.00K 10-Q · filed 2023-08-10 | $501.00K derived: sum of 3 quarters · filed 2023-08-10 | $624.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $154.00K 10-Q · filed 2023-05-11 | $280.00K derived: sum of 2 quarters · filed 2023-05-11 | $403.00K derived: sum of 3 quarters · filed 2023-05-11 | $521.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $249.00K derived: sum of 2 quarters · filed 2023-03-23 | $367.00K derived: sum of 3 quarters · filed 2023-03-23 | $479.00K 10-K · filed 2023-03-23 | |
| 2021-09-30 | $123.00K 10-Q · filed 2022-11-10 | $241.00K derived: sum of 2 quarters · filed 2022-11-10 | $353.00K 10-Q · filed 2022-11-10 | $355.00K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $118.00K 10-Q · filed 2022-08-15 | $230.00K 10-Q · filed 2022-08-15 | $232.00K derived: sum of 3 quarters · filed 2022-08-15 | $232.00K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $112.00K 10-Q · filed 2022-05-12 | $114.00K derived: sum of 2 quarters · filed 2022-05-12 | $114.00K derived: sum of 3 quarters · filed 2022-05-12 | $114.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $2.00K derived: sum of 2 quarters · filed 2022-03-28 | $2.00K derived: sum of 3 quarters · filed 2022-03-28 | $2.00K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | $2.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |